Skip to main content
. 2023 Nov 8;39(6):944–955. doi: 10.1093/ndt/gfad237

Figure 1:

Figure 1:

Proposed therapeutic algorithm for the management of GPA and MPA. GC, glucocorticoid; RTX, rituximab; CYC, cyclophosphamide; MMF, mycophenolate mofetil; MTX, methotrexate; IVIG, intravenous immunoglobulin; AZA, azathioprine; TMP-SMX, trimethoprim/sulfamethoxazole.